The Placental Epigenome in Preterm Birth: From Cellular Heterogeneity to Liquid Biopsy Biomarkers
Open Access
- 2 November 2026
- journal article
- review article
- Published by MDPI AG in Epigenomes
- Vol. 10 (4) , 69
Abstract
Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality worldwide, with limited tools for early prediction or targeted prevention. Increasing evidence identifies the placenta as a central regulator of gestational duration, and alterations in placental gene regulatory programs have been associated with PTB. This review synthesizes recent advances in placental genomics and epigenomics, emphasizing how cell-type-specific regulatory landscapes shape PTB risk. We describe how DNA methylation, chromatin accessibility, and transcriptional heterogeneity across trophoblasts, Hofbauer cells, endothelial cells, Natural Killer (NK) cells, and mesenchymal stromal cells integrate maternal, fetal, immune, and environmental signals. We further evaluate emerging liquid biopsy approaches, focusing on circulating cell-free placental DNA (cfpDNA) methylation as a minimally invasive strategy to detect placental dysfunction. Single-cell and long-read sequencing technologies have enabled high-resolution mapping of placental regulatory architecture, revealing cell-type-specific pathways underlying inflammation, impaired trophoblast differentiation, and aberrant vascular remodeling. These studies support the investigation of placental epigenetic alterations as potential contributors to PTB-associated biology, although their causal roles and consistency across PTB subtypes remain uncertain. Circulating cfpDNA methylation profiles are being investigated as minimally invasive indicators of placental biology, but their accuracy and clinical utility for PTB prediction require further validation. Together, these findings suggest that epigenomic alterations may be associated with biological pathways implicated in PTB and may also provide measurable molecular signatures in maternal circulation.Keywords
Funding Information
- National Institute on Minority Health and Health Disparities (R01MD017690)
- National Institute on Minority Health and Health Disparities (T32GM152760)
- National Institute on Minority Health and Health Disparities (U54HG013595)
This publication has 163 references indexed in Scilit:
- FIGO good practice recommendations on preconception care: A strategy to prevent preterm birthInternational Journal of Gynecology & Obstetrics, 2025
- The landscape of decidual immune cells at the maternal–fetal interface in parturition and preterm birthInflammation Research, 2025
- Macrophage plasticity: signaling pathways, tissue repair, and regenerationMedcomm, 2024
- Distinctive aspects of the placental epigenome and theories as to how they ariseCellular and Molecular Life Sciences, 2022
- Epigenetics of pregnancy: looking beyond the DNA codeJournal of Assisted Reproduction and Genetics, 2022
- Reliability of a novel approach for reference-based cell type estimation in human placental DNA methylation studiesCellular and Molecular Life Sciences, 2022
- Deregulation of imprinted genes expression and epigenetic regulators in placental tissue from intrauterine growth restrictionJournal of Assisted Reproduction and Genetics, 2021
- Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomesPrenatal Diagnosis, 2016
- High levels of fetal DNA are associated with increased risk of spontaneous preterm deliveryPrenatal Diagnosis, 2012
- The role of imprinted genes in fetal growth abnormalitiesBirth Defects Research Part A: Clinical and Molecular Teratology, 2011